A new role for an old protein in breast cancer

Scientists led by Dr Chris Toseland of the University's School of Biosciences studied a protein called Myosin VI, a molecular motor which acts as a courier to transport other proteins within our cells. Myosin VI is highly present in many cancers yet the role is unclear. Dr Toseland's study to understand the role of Myosin VI found it was critical in the production of specific genes which are linked to cell growth and tumour development. This is particularly relevant to breast, ovarian, prostate and colon cancer.

Approximately 70% of all breast cancer is oestrogen sensitive and the results of this study may identify new treatment targets for patients with the disease. As a result of his findings, Dr Toseland is now inviting patients in the NHS to take part in further research. This will investigate how myosins are targeted to specific genes, and determine how they are themselves regulated, enhancing scientists understanding of their function during breast cancer.

Understanding the role of Myosin VI in the disease may also highlight further diagnostic clues for the disease. This would potentially allow for a better choice of treatment to be administered.

Kent researchers have identified how few mutations it can take for Ebolaviruses to adapt to affect previously resistant species.
Ebola is one of the world's most virulent diseases, though rodent species such as guinea pigs, rats and mice are not normally susceptible to it. However, through ... more

analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by LUMITOS GmbH, one of analytica's official sales partners.